| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 09/19/2002 | WO2002004953A3 Novel tumor antigen useful in diagnosis and therapy of bladder, ovary, lung and kidney cancers |
| 09/19/2002 | WO2002004664A9 Genes comprising coding mononucleotide microsatellites or dinucleotide microsatellites that can be isolated from tumour cells |
| 09/19/2002 | WO2002004487A3 Method for producing and using novel human defensins as biologically active proteins for treating infections and other illnesses |
| 09/19/2002 | WO2002002765A3 Chimeric promoters for controlling expression in smooth muscle cells |
| 09/19/2002 | WO2002000870A9 Method for transfecting cells using a magnetic field |
| 09/19/2002 | WO2001092299A9 Adenovirus particles with mutagenized fiber proteins |
| 09/19/2002 | WO2001083783A3 In vivo loading of mhc |
| 09/19/2002 | WO2001083729A3 Vectors for ocular transduction and use thereof for genetic therapy |
| 09/19/2002 | WO2001083514A3 Nucleic acids encoding a regulator of a g protein signaling, rgs18, and uses thereof |
| 09/19/2002 | WO2001080902A3 A particulate complex for administering nucleic acid into a cell |
| 09/19/2002 | WO2001064949A3 Diagnostics and therapeutics for glaucoma |
| 09/19/2002 | WO2001030843A9 Ligand activated transcriptional regulator proteins |
| 09/19/2002 | WO2001014579A9 Compositions and methods for delivery of an agent using attenuated salmonella containing phage |
| 09/19/2002 | US20020133835 Genetically engineering vertebrate germ cells; obtain gonads, incubate in transfection mixture and nucleotide sequences, transfect, recover transfected germ cells |
| 09/19/2002 | US20020133834 Test and model for alzheimer's disease |
| 09/19/2002 | US20020133126 Transfection system, its preparation and use in somatic gene therapy |
| 09/19/2002 | US20020132995 Modulation of immune response to preferential nucleotide sequences; obtain nucleotide sequence sample, insert adjusted nucleotides, administer to mammals monitor immune response |
| 09/19/2002 | US20020132994 Nucleotide sequences coding polypeptide for use in the treatment and prevention of microorganismal infections |
| 09/19/2002 | US20020132990 Bioengineered vehicles for targeted nucleic acid delivery |
| 09/19/2002 | US20020132789 Especially for rickettsial pathogen selected from the group consisting of Rickettsia spp., Ehrlichia spp., Anaplasma spp., and Cowdria |
| 09/19/2002 | US20020132788 Inhibition of gene expression by delivery of small interfering RNA to post-embryonic animal cells in vivo |
| 09/19/2002 | US20020132787 Compositions and methods for nucleic acid delivery to the lung |
| 09/19/2002 | US20020132785 Diagnosis and treatment of cancer or a cellular proliferation and/or differentiation or hematopoietic disorder; evaluation of the efficacy of cancer treatments |
| 09/19/2002 | US20020132774 Neuropilin antagonist that binds neuropilin and has VEGF antagonist activity as determined by the human umbilical vein endothelial cell proliferation assay using VEGF165; treatment of metastatic cancer, and angiogenic diseases. |
| 09/19/2002 | US20020132769 Comprising a soluble adenoviral receptor domain, a trimerization domain, and a targeting ligand domain; using molecule to treat a disease, such as cancer, with adenoviral gene therapy; side effect reduction |
| 09/19/2002 | US20020132767 Nucleic acids, proteins, and antibodies |
| 09/19/2002 | US20020132753 Nucleic acids, proteins, and antibodies |
| 09/19/2002 | US20020132347 Genetically engineered cell for use in the diagnosis, prevntion and treatment of viral diseases |
| 09/19/2002 | US20020132337 Processes for preparation of marek's disease virus using continuous avian cell lines |
| 09/19/2002 | US20020132324 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 09/19/2002 | US20020132321 14790, Novel protein kinase molecule and uses therefor |
| 09/19/2002 | US20020132306 Premature antihemopliic factor; for use in the treatment of blood disorders |
| 09/19/2002 | US20020132302 TMOF receptor and uses thereof |
| 09/19/2002 | US20020132298 Nucleotide sequences coding polypeptide for use in the treatment of muscular and nervous sytem disosrders |
| 09/19/2002 | US20020132297 Nucleotide sequences coding protein for use in the treatment nflammatory bowel disease, sepsis, viral diseases and rheumatoid arthritis |
| 09/19/2002 | US20020132296 Human Ste20-like stress activated serine/threonine kinase |
| 09/19/2002 | US20020132223 Methods for modulating activity of the FXR nuclear receptor |
| 09/19/2002 | US20020131965 Conjugate of a bioactive agent covalently attached to a transport polymer, having guanidino or amidino side chains, such as an arginine-containing polypeptide |
| 09/19/2002 | US20020131961 Gene transfer of Bcl2 and a selected transgene to cells; Bcl2 protects cells which express it from apoptosis so they can be selected by administering an apoptotic agent |
| 09/19/2002 | US20020131959 Contacting an organ, tissue or cells with transforming growth factor beta 1 (TGF beta 1) |
| 09/19/2002 | US20020131956 Adeno-associated virus vectors encoding factor VIII and methods of using the same |
| 09/19/2002 | US20020131951 Biodegradable poly(beta-amino esters) and uses thereof |
| 09/19/2002 | CA2470152A1 Transfection complexes comprising a novel peptide as cell surface receptor binding component |
| 09/19/2002 | CA2454959A1 Mva expressing modified hiv envelope, gag, and pol genes |
| 09/19/2002 | CA2441454A1 Recombinant adeno-associated virus-mediated gene transfer via retroductal infusion of virions |
| 09/19/2002 | CA2441082A1 Steap-related protein |
| 09/19/2002 | CA2440342A1 Avidin-pseudotyped viral vectors and their use |
| 09/19/2002 | CA2439702A1 Nucleic acids of the human abcc11 gene, vectors containing such nucleic acids and uses thereof |
| 09/19/2002 | CA2439654A1 Compositions and methods for modifying the content of polyunsaturated fatty acids in mammalian cells |
| 09/19/2002 | CA2439612A1 Modulation of smooth muscle cell proliferation |
| 09/19/2002 | CA2439188A1 Mhc-i-restricted presentation of hiv-1 virion antigens without viral replication. application to the stimulation of ctl and vaccination in vivo; analysis of vaccinating composition in vitro |
| 09/19/2002 | CA2437960A1 Als2 gene and amyotrophic lateral sclerosis type 2 |
| 09/18/2002 | EP1241259A1 Peptide having pronociceptive properties |
| 09/18/2002 | EP1241258A2 Stem cell factor |
| 09/18/2002 | EP1241254A1 Apoptosis inhibitory polypeptide, gene and polynucleotide encoding it and compositions containing the same |
| 09/18/2002 | EP1240521A2 Identification of disease markers involving mass-based-separation |
| 09/18/2002 | EP1240358A1 T1 receptor-like ligand ii and uses thereof |
| 09/18/2002 | EP1240345A2 Methods for expression of genes in primates |
| 09/18/2002 | EP1240344A1 Replication incompetent herpes viruses for use in gene therapy |
| 09/18/2002 | EP1240343A2 Nucleic acid vaccine compositions having a mammalian cd80/cd86 gene promoter driving antigen expression |
| 09/18/2002 | EP1240332A2 Streptococcus pyogenes virulence genes and proteins and their use |
| 09/18/2002 | EP1240331A2 i CHLAMYDIA /i ANTIGENS AND CORRESPONDING DNA FRAGMENTS AND USES THEREOF |
| 09/18/2002 | EP1240329A2 i STREPTOCOCCUS PNEUMONIAE /i ANTIGENS |
| 09/18/2002 | EP1240328A1 Antigenic protein lppq of mycoplasma mycoides subsp. mycoides sc., its preparation and use |
| 09/18/2002 | EP1240327A2 Interferon-like molecules and uses thereof |
| 09/18/2002 | EP1240324A2 Polypeptides and nucleic acids encoding same |
| 09/18/2002 | EP1240322A2 Therapeutic uses of lna-modified oligonucleotides |
| 09/18/2002 | EP1240317A2 Nucleic acid vaccination |
| 09/18/2002 | EP1240313A2 Homologues of human heparanase and splice variants thereof |
| 09/18/2002 | EP1240202A2 Inhibitors of complement activation, their preparation and use |
| 09/18/2002 | EP1240199A2 Method for screening of appetite control agents |
| 09/18/2002 | EP1240197A1 Interleukin-1 receptor antagonist-like molecules and uses thereof |
| 09/18/2002 | EP1240196A2 Basolateral sorting signal based on scf peptide and inhibitors thereof |
| 09/18/2002 | EP1240190A1 Uses of transport proteins for controlling cell cycle |
| 09/18/2002 | EP1240186A2 Improvements in or relating to immune responses to hiv |
| 09/18/2002 | EP1239870A1 Interleukin-1 receptor antagonist-like molecules and uses thereof |
| 09/18/2002 | EP1239869A2 Tweak receptor |
| 09/18/2002 | EP1239855A2 Method for the prevention and/or treatment of atherosclerosis |
| 09/18/2002 | EP1239848A2 Compositions and methods for modulating hdl cholesterol and triglyceride levels |
| 09/18/2002 | EP1239834A2 Mixed structures resulting from the incorporation of a biological macromolecule, especially of dna, in a liquid crystal phase of amphiphiles, and vesicles obtained using these structures |
| 09/18/2002 | EP1239776A2 Surgical needle with weeping tip and method of use |
| 09/18/2002 | EP1212339A4 2'-o-acetamido modified monomers and oligomers |
| 09/18/2002 | EP1180113A4 Oligonucleotides having a-dna form and b-dna form conformational geometry |
| 09/18/2002 | EP0943015B1 Method and apparatus for preparing sample cartridges for a particle acceleration device |
| 09/18/2002 | EP0842267B1 Mch2, AN APOPTOTIC CYSTEINE PROTEASE, AND COMPOSITIONS FOR MAKING AND METHODS OF USING THE SAME |
| 09/18/2002 | EP0693936B1 Cloned leptospira outer membrane protein |
| 09/18/2002 | EP0614486B1 Targeted delivery of virus vector to mammalian cells |
| 09/18/2002 | CN1370240A Regulation system of expression using nuclear PPAR receptors |
| 09/18/2002 | CN1370237A Recombinant parainfluenza virus vaccines attenuated by deletion or ablation of non-essential gene |
| 09/18/2002 | CN1370231A CASB618 polynucleotides and polypeptides and their use |
| 09/18/2002 | CN1370182A Compounds and methods for therapy and diagnosis of lung cancer |
| 09/18/2002 | CN1370083A Ninovasive genetic immnization, expression products therefrom, and uses thereof |
| 09/18/2002 | CN1091111C Structure and usage of antisense oligonucleotide for treating diseases correlative to hepatitis C virus |
| 09/18/2002 | CN1090937C Prepn. of EIA-specicial medicinal compond for making medicine for resisting heat-cervical tumor and its application |
| 09/17/2002 | US6451994 Polypeptides, polynucleotides; drug screening; diagnosing alzheimer*s, parkinson*s, huntington*s, and creutzfelt-jacob disease; amyotrophic lateral sclerosis, cystic fibrosis |
| 09/17/2002 | US6451981 Inhibitor of cellular adhesion, migration or infiltration into areas of tissue damage, injury, or transplant |
| 09/17/2002 | US6451968 Hoogsteen type base pairing in triplex motif; diagnosis; heat resistance; detection of point mutations, restriction enzyme sites, and transcription inhibition |
| 09/17/2002 | US6451840 Regulation of T cell-mediated immunity by tryptophan |
| 09/17/2002 | US6451770 A liquid jet intradermal administration apparatus that administers an immunogenic composition or vaccine to an animal: without a needle, and into the epidermis, dermis and/or hypodermis; wherein the apparatus includes an |
| 09/17/2002 | US6451769 Compositions and methods for administering Borrelia DNA |